Critical Reviews in Oncology / Hematology
Volume 43, Issue 2 , Pages 135-139 , August 2002

Radical perineal prostatectomy: a model for evaluating local response of prostate therapy

,Accepted 9 November 2001.

References 

  1. Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC. Pathological factors that influence prognosis in stage A prostate cancer: the influence of extent versus grade. J. Urol. 1981;125:516
  2. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53:457
  3. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In:  Tannenbaum M editors. Urologic pathology: the prostate. 10:Philadelphia: Lea & Febiger; 1977;p. 171–198
  4. Murphy GP, Whitmore WF. A report of the workshops on the current status of the histopathologic grading of prostate cancer. Cancer. 1979;44:1490
  5. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum. Pathol. 1992;23:273
  6. Grayhack JT, Assimos DG. Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. Prostate. 1983;4:13
  7. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J. Urol. 1994;152:1826
  8. Pound PR, Partin AW, Epstein J, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control. Urol. Clin. North Am. 1997;20:395
  9. Coetzee LJ, Layfield LJ, Hars V, Paulson DF. Proliferative index determination on prostatic carcinoma tissue, any additional prognostic value above Gleason score, ploidy and pathological stage?. J. Urol. 1997;157:214
  10. Norberg M, Holmberg L, Wheeler T, Magnusson A. Five years follow-up after radical prostatectomy for localized prostate cancer—a study of the impact of different tumor variables on progression. Scand. J. Urol. Nephrol. 1994;28:391
  11. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J. Urol. 1996;156:137
  12. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up. J. Urol. 1993;149:1478
  13. Partin AW, Piantadosi S, Sanda MG, et al.  Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology. 1995;45:831
  14. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?. J. Urol. 1994;152:1843
  15. Zincke H, Oesterling JE, Blute ML, Bergstrahl EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J. Urol. 1994;152:1850
  16. Ohori M, Wheeler TM, Kattan MW, Gotto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol. 1995;154:1818

PII: S1040-8428(02)00025-2

Critical Reviews in Oncology / Hematology
Volume 43, Issue 2 , Pages 135-139 , August 2002

Article Tools

* Image Usage & Resolution